{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T05:47:36Z","timestamp":1794203256267,"version":"4.8.0"},"reference-count":220,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T00:00:00Z","timestamp":1706313600000},"content-version":"vor","delay-in-days":1152,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"vor","delay-in-days":685,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Amolyt"},{"name":"Ascendis"},{"name":"Calcilytix"},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["asbmr.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>The last international guidelines on the evaluation and management of primary hyperparathyroidism (PHPT) were published in 2014. Research since that time has led to new insights into epidemiology, pathophysiology, diagnosis, measurements, genetics, outcomes, presentations, new imaging modalities, target and other organ systems, pregnancy, evaluation, and management. Advances in all these areas are demonstrated by the reference list in which the majority of listings were published after the last set of guidelines. It was thus, timely to convene an international group of over 50 experts to review these advances in our knowledge. Four Task Forces considered: 1. Epidemiology, Pathophysiology, and Genetics; 2. Classical and Nonclassical Features; 3. Surgical Aspects; and 4. Management. For Task Force 4 on the Management of PHPT, Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) methodology addressed surgical management of asymptomatic PHPT and non-surgical medical management of PHPT. The findings of this systematic review that applied GRADE methods to randomized trials are published as part of this series. Task Force 4 also reviewed a much larger body of new knowledge from observations studies that did not specifically fit the criteria of GRADE methodology. The full reports of these 4 Task Forces immediately follow this summary statement. Distilling the essence of all deliberations of all Task Force reports and Methodological reviews, we offer, in this summary statement, evidence-based recommendations and guidelines for the evaluation and management of PHPT. Different from the conclusions of the last workshop, these deliberations have led to revisions of renal guidelines and more evidence for the other recommendations. The accompanying papers present an in-depth discussion of topics summarized in this report. \u00a9 2022 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).<\/jats:p>","DOI":"10.1002\/jbmr.4677","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T08:43:13Z","timestamp":1660898593000},"page":"2293-2314","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":594,"title":["Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1570-2617","authenticated-orcid":false,"given":"John P.","family":"Bilezikian","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Department of Medicine Vagelos College of Physicians and Surgeons, Columbia University New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3733-8956","authenticated-orcid":false,"given":"Aliya A.","family":"Khan","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism McMaster University Hamilton ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1074-2679","authenticated-orcid":false,"given":"Shonni J.","family":"Silverberg","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine Vagelos College of Physicians and Surgeons, Columbia University New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2076-5858","authenticated-orcid":false,"given":"Ghada El-Hajj","family":"Fuleihan","sequence":"additional","affiliation":[{"name":"Calcium Metabolism and Osteoporosis Program, WHO CC for Metabolic Bone Disorders, Division of Endocrinology American University of Beirut Beirut Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6568-8588","authenticated-orcid":false,"given":"Claudio","family":"Marcocci","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine University of Pisa, Endocrine Unit 2, University Hospital of Pisa Pisa Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6525-0439","authenticated-orcid":false,"given":"Salvatore","family":"Minisola","sequence":"additional","affiliation":[{"name":"Department of Clinical, Internal, Anaesthesiologic and Cardiovascular Sciences, \u2018Sapienza\u2019 Rome University Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5933-1005","authenticated-orcid":false,"given":"Nancy","family":"Perrier","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology University of Texas MD Anderson Cancer Center Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0355-7325","authenticated-orcid":false,"given":"Antonio","family":"Sitges-Serra","sequence":"additional","affiliation":[{"name":"Department of Surgery, Universitat Aut\u00f2noma de Barcelona Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1438-3220","authenticated-orcid":false,"given":"Rajesh V.","family":"Thakker","sequence":"additional","affiliation":[{"name":"Academic Endocrine Unit, Radcliffe Department of Medicine University of Oxford, Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), Churchill Hospital Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2352-5718","authenticated-orcid":false,"given":"Gordon","family":"Guyatt","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence and Impact McMaster University Hamilton ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0867-9778","authenticated-orcid":false,"given":"Michael","family":"Mannstadt","sequence":"additional","affiliation":[{"name":"Endocrine Unit, Department of Medicine Massachusetts General Hospital and Harvard Medical School Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3772-3432","authenticated-orcid":false,"given":"John T.","family":"Potts","sequence":"additional","affiliation":[{"name":"Endocrine Unit, Department of Medicine Massachusetts General Hospital and Harvard Medical School Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3801-9546","authenticated-orcid":false,"given":"Bart L.","family":"Clarke","sequence":"additional","affiliation":[{"name":"Mayo Clinic Division of Endocrinology, Diabetes, Metabolism, and Nutrition Mayo Clinic Rochester MN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8741-0592","authenticated-orcid":false,"given":"Maria Luisa","family":"Brandi","sequence":"additional","affiliation":[{"name":"Fondazione Italiana sulla Ricerca sulle Malattie dell'Osso (F.I.R.M.O. Foundation) Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of the International Workshop on Primary Hyperparathyroidism","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"issue":"10","key":"2024012714065944400_jbmr4677-bib-0001","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2024012714065944400_jbmr4677-bib-0002","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jclinepi.2012.03.013","article-title":"GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations","volume":"66","author":"Andrews","year":"2013","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"2024012714065944400_jbmr4677-bib-0003","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1002\/jbmr.4665","article-title":"Epidemiology, pathophysiology and genetics of primary hyperparathyroidism","volume":"37","author":"Minisola","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2024012714065944400_jbmr4677-bib-0004","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1002\/jbmr.4679","article-title":"Classical and non-classical manifestations of primary hyperparathyroidism","volume":"37","author":"El-Hajj Fuleihan","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2024012714065944400_jbmr4677-bib-0005","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1002\/jbmr.4689","article-title":"Surgical aspects of primary hyperparathyroidism","volume":"37","author":"Perrier","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2024012714065944400_jbmr4677-bib-0006","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/jbmr.4682","article-title":"Management of primary hyperparathyroidism","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2024012714065944400_jbmr4677-bib-0007","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1002\/jbmr.4685","article-title":"The efficacy and safety of medical and surgical therapy in patients with primary hyperparathyroidism: a systematic review and meta-analysis of randomized controlled trials","volume":"37","author":"Ye","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2024012714065944400_jbmr4677-bib-0008","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1002\/jbmr.4687","article-title":"Methodology for the guidelines on evaluation and management of hypoparathyroidism and primary hyperparathyroidism","volume":"37","author":"Yao","year":"2022","journal-title":"J Bone Miner Res"},{"key":"2024012714065944400_jbmr4677-bib-0009","article-title":"Epidemiology and financial burden of adult chronic hypoparathyroidism","author":"Bjornsdottir","year":"2022","journal-title":"J Bone Miner Res"},{"key":"2024012714065944400_jbmr4677-bib-0010","article-title":"Etiology and pathophysiology of hypoparathyroidism: a narrative review","author":"Pasieka","year":"2022","journal-title":"J Bone Miner Res"},{"key":"2024012714065944400_jbmr4677-bib-0011","article-title":"Hypoparathyroidism: genetics and diagnosis","author":"Mannstadt","year":"2022","journal-title":"J Bone Miner Res"},{"key":"2024012714065944400_jbmr4677-bib-0012","article-title":"Management of hypoparathyroidism","author":"Khan","year":"2022","journal-title":"J Bone Miner Res"},{"key":"2024012714065944400_jbmr4677-bib-0013","article-title":"Evaluation and management of hypoparathyroidism summary statement and guidelines from the second international workshop","author":"Khan","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2024012714065944400_jbmr4677-bib-0014","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/0002-9343(81)90382-X","article-title":"Reporting of phosphate and phosphorus plasma values","volume":"71","author":"Bartter","year":"1981","journal-title":"Am J Med"},{"key":"2024012714065944400_jbmr4677-bib-0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2014.12.003","article-title":"Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010)","volume":"73","author":"Griebeler","year":"2015","journal-title":"Bone"},{"issue":"3","key":"2024012714065944400_jbmr4677-bib-0016","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population","volume":"98","author":"Yeh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024012714065944400_jbmr4677-bib-0017","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198001243020402","article-title":"Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community","volume":"302","author":"Heath","year":"1980","journal-title":"N Engl J Med"},{"issue":"3","key":"2024012714065944400_jbmr4677-bib-0018","doi-asserted-by":"crossref","first-page":"e0230130","DOI":"10.1371\/journal.pone.0230130","article-title":"Epidemiology and management of parathyroid gland disorders in Spain over 15\u2009years: a retrospective multicentre analysis","volume":"15","author":"Darba","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"2024012714065944400_jbmr4677-bib-0019","first-page":"A4567","article-title":"Increasing incidence of primary hyperparathyroidism in Denmark","volume":"60","author":"Abood","year":"2013","journal-title":"Dan Med J"},{"issue":"1","key":"2024012714065944400_jbmr4677-bib-0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jocd.2012.12.001","article-title":"Normocalcemic primary hyperparathyroidism","volume":"16","author":"Cusano","year":"2013","journal-title":"J Clin Densitom"},{"issue":"9","key":"2024012714065944400_jbmr4677-bib-0021","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1590\/S0100-879X2005000900013","article-title":"Changes in clinical and laboratory findings at the time of diagnosis of primary hyperparathyroidism in a university hospital in Sao Paulo from 1985 to 2002","volume":"38","author":"Ohe","year":"2005","journal-title":"Braz J Med Biol Res"},{"key":"2024012714065944400_jbmr4677-bib-0022","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4137\/CMED.S13147","article-title":"Epidemiology of primary hyperparathyroidism and its non-classical manifestations in the City of Recife, Brazil","volume":"6","author":"Eufrazino","year":"2013","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"issue":"2","key":"2024012714065944400_jbmr4677-bib-0023","doi-asserted-by":"crossref","first-page":"112","DOI":"10.14712\/23362936.2015.50","article-title":"Changes in the pattern of primary hyperparathyroidism in Czech Republic","volume":"116","author":"Broulik","year":"2015","journal-title":"Prague Med Rep"},{"key":"2024012714065944400_jbmr4677-bib-0024","first-page":"200","article-title":"The prevalence of hyperparathyroidism in the Bulgarian population\u2014analysis of an epidemiological study by the Bulgarian Society of Endocrinology (BSE)","volume":"XXIV","author":"Borissova","year":"2012","journal-title":"Endocrinologia"},{"issue":"5","key":"2024012714065944400_jbmr4677-bib-0025","doi-asserted-by":"crossref","first-page":"300","DOI":"10.14341\/probl10126","article-title":"Primary hyperparathyroidism in Russia according to the registry","volume":"65","author":"Mokrysheva","year":"2019","journal-title":"Probl Endokrinol"},{"issue":"2","key":"2024012714065944400_jbmr4677-bib-0026","first-page":"105","article-title":"Primary hyperparathyroidism in developing world: a systematic review on the changing clinical profile of the disease","volume":"64","author":"Yadav","year":"2020","journal-title":"Arch Endocrinol Metab"},{"key":"2024012714065944400_jbmr4677-bib-0027","doi-asserted-by":"crossref","first-page":"6282687","DOI":"10.1155\/2018\/6282687","article-title":"Comparison of initial clinical presentations between primary hyperparathyroidism patients from New Brunswick and Changsha","volume":"2018","author":"Meng","year":"2018","journal-title":"Int J Endocrinol"},{"issue":"2","key":"2024012714065944400_jbmr4677-bib-0028","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1210\/jc.2012-2914","article-title":"The changing clinical patterns of primary hyperparathyroidism in Chinese patients: data from 2000 to 2010 in a single clinical center","volume":"98","author":"Zhao","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024012714065944400_jbmr4677-bib-0029","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00774-018-0922-3","article-title":"The characteristics of clinical changes in primary hyperparathyroidism in Chinese patients","volume":"37","author":"Yao","year":"2019","journal-title":"J Bone Miner Metab"},{"issue":"3","key":"2024012714065944400_jbmr4677-bib-0030","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00198-017-4322-7","article-title":"Characteristics, management, and outcome of primary hyperparathyroidism at a single clinical center from 2005 to 2016","volume":"29","author":"Sun","year":"2018","journal-title":"Osteoporos Int"},{"issue":"2","key":"2024012714065944400_jbmr4677-bib-0031","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4248\/BR201302005","article-title":"Primary hyperparathyroidism: a tale of two cities revisited\u2014New York and Shanghai","volume":"1","author":"Liu","year":"2013","journal-title":"Bone Res"},{"issue":"2","key":"2024012714065944400_jbmr4677-bib-0032","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0002-9343(87)90068-4","article-title":"Acute primary hyperparathyroidism","volume":"82","author":"Fitzpatrick","year":"1987","journal-title":"Am J Med"},{"issue":"6","key":"2024012714065944400_jbmr4677-bib-0033","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/BF01670531","article-title":"Premature death in patients operated on for primary hyperparathyroidism","volume":"14","author":"Hedb\u00e4ck","year":"1990","journal-title":"World J Surg"},{"issue":"2","key":"2024012714065944400_jbmr4677-bib-0034","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0039-6060(05)80076-5","article-title":"Parathyroid adenoma weight and the risk of death after treatment for primary hyperparathyroidism","volume":"117","author":"Hedb\u00e4ck","year":"1995","journal-title":"Surgery"},{"issue":"4","key":"2024012714065944400_jbmr4677-bib-0035","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1365-2362.1998.00289.x","article-title":"Increased risk of death from primary hyperparathyroidism\u2014an update","volume":"28","author":"Hedb\u00e4ck","year":"1998","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"2024012714065944400_jbmr4677-bib-0036","first-page":"1","article-title":"Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979","volume":"102","author":"Palm\u00e9r","year":"1987","journal-title":"Surgery"},{"issue":"6","key":"2024012714065944400_jbmr4677-bib-0037","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1067\/msy.2001.118377","article-title":"Increased cardiovascular mortality and normalized serum calcium in patients with mild hypercalcemia followed up for 25\u2009years","volume":"130","author":"Lundgren","year":"2001","journal-title":"Surgery"},{"issue":"2","key":"2024012714065944400_jbmr4677-bib-0038","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2265.2010.03958.x","article-title":"A record linkage study of outcomes in patients with mild primary hyperparathyroidism: the Parathyroid Epidemiology and Audit Research Study (PEARS)","volume":"75","author":"Yu","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024012714065944400_jbmr4677-bib-0039","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bone.2014.12.067","article-title":"Mortality associated with primary hyperparathyroidism","volume":"74","author":"Clifton-Bligh","year":"2015","journal-title":"Bone"},{"issue":"2","key":"2024012714065944400_jbmr4677-bib-0040","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9343(97)00270-2","article-title":"Survival after the diagnosis of hyperparathyroidism: a population-based study","volume":"104","author":"Wermers","year":"1998","journal-title":"Am J Med"},{"issue":"6","key":"2024012714065944400_jbmr4677-bib-0041","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0039-6060(97)90216-6","article-title":"Survival after surgical treatment for primary hyperparathyroidism","volume":"122","author":"S\u00f6reide","year":"1997","journal-title":"Surgery"},{"issue":"9","key":"2024012714065944400_jbmr4677-bib-0042","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1210\/jc.2018-02483","article-title":"Predictors of nephrolithiasis, osteoporosis, and mortality in primary hyperparathyroidism","volume":"104","author":"Reid","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024012714065944400_jbmr4677-bib-0043","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/cen.12206","article-title":"What predicts adverse outcomes in untreated primary hyperparathyroidism? The Parathyroid Epidemiology and Audit Research Study (PEARS)","volume":"79","author":"Yu","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"2024012714065944400_jbmr4677-bib-0044","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1210\/clinem\/dgaa419","article-title":"Reduced calcium sensing receptor (CaSR) expression is epigenetically deregulated in parathyroid adenomas","volume":"105","author":"Singh","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024012714065944400_jbmr4677-bib-0045","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2265.2000.00933.x","article-title":"Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia","volume":"52","author":"Corbetta","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024012714065944400_jbmr4677-bib-0046","first-page":"247","volume-title":"Dynamics of Bone and Cartilage Metabolism","author":"Rizzoli","year":"1999"},{"issue":"3","key":"2024012714065944400_jbmr4677-bib-0047","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.beem.2013.02.006","article-title":"Role of the calcium-sensing receptor in extracellular calcium homeostasis","volume":"27","author":"Brown","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"2024012714065944400_jbmr4677-bib-0048","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41574-018-0115-0","article-title":"The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases","volume":"15","author":"Hannan","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"2024012714065944400_jbmr4677-bib-0049","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cell.2008.08.040","article-title":"Anatomical profiling of G protein-coupled receptor expression","volume":"135","author":"Regard","year":"2008","journal-title":"Cell"},{"issue":"5","key":"2024012714065944400_jbmr4677-bib-0050","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1210\/jcem.87.5.8492","article-title":"Mitogen-activated protein kinase cascade in human normal and tumoral parathyroid cells","volume":"87","author":"Corbetta","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"16","key":"2024012714065944400_jbmr4677-bib-0051","doi-asserted-by":"crossref","first-page":"E3749","DOI":"10.1073\/pnas.1717754115","article-title":"Interrelated role of Klotho and calcium-sensing receptor in parathyroid hormone synthesis and parathyroid hyperplasia","volume":"115","author":"Fan","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024012714065944400_jbmr4677-bib-0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000486060","article-title":"Physiology of the calcium-parathyroid hormone-vitamin D Axis","volume":"50","author":"Goltzman","year":"2018","journal-title":"Front Horm Res"},{"issue":"1-2","key":"2024012714065944400_jbmr4677-bib-0053","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jsbmb.2012.01.010","article-title":"Distribution and regulation of the 25-hydroxyvitamin D3 1alpha-hydroxylase in human parathyroid glands","volume":"130","author":"Ritter","year":"2012","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"2024012714065944400_jbmr4677-bib-0054","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41574-021-00477-2","article-title":"Hormonal regulation of biomineralization","volume":"17","author":"Arnold","year":"2021","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"2024012714065944400_jbmr4677-bib-0055","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1172\/JCI108815","article-title":"Role of 1,25-dihydroxyvitamin D3 on intestinal phosphate absorption in rats with a normal vitamin D supply","volume":"60","author":"Rizzoli","year":"1977","journal-title":"J Clin Invest"},{"issue":"3","key":"2024012714065944400_jbmr4677-bib-0056","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1210\/clinem\/dgaa895","article-title":"Role of gut microbiota in the skeletal response to PTH","volume":"106","author":"Pacifici","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2024012714065944400_jbmr4677-bib-0057","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1210\/jc.2018-01225","article-title":"Primary hyperparathyroidism","volume":"103","author":"Bilezikian","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2024012714065944400_jbmr4677-bib-0058","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000491039","article-title":"Parathyroid carcinoma","volume":"51","author":"Cetani","year":"2019","journal-title":"Front Horm Res"},{"issue":"7","key":"2024012714065944400_jbmr4677-bib-0059","doi-asserted-by":"crossref","first-page":"R441","DOI":"10.1530\/ERC-19-0135","article-title":"Atypical parathyroid adenomas: challenging lesions in the diagnosis of endocrine tumors","volume":"26","author":"Cetani","year":"2019","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"2024012714065944400_jbmr4677-bib-0060","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00423-016-1373-8","article-title":"Multigland primary hyperparathyroidism\u2014frequently considered, seldom encountered","volume":"400","author":"Mihai","year":"2016","journal-title":"Langenbecks Arch Surg"},{"issue":"3","key":"2024012714065944400_jbmr4677-bib-0061","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.amjmed.2014.09.030","article-title":"Hypercalcemic crisis: a clinical review","volume":"128","author":"Ahmad","year":"2015","journal-title":"Am J Med"},{"issue":"3","key":"2024012714065944400_jbmr4677-bib-0062","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.5650040302","article-title":"Skeletal disease in primary hyperparathyroidism","volume":"4","author":"Silverberg","year":"1989","journal-title":"J Bone Miner Res"},{"issue":"Suppl 2","key":"2024012714065944400_jbmr4677-bib-0063","first-page":"N103","article-title":"Fracture risk in primary hyperparathyroidism","volume":"17","author":"Khosla","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2024012714065944400_jbmr4677-bib-0064","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jocd.2012.11.013","article-title":"Skeletal effects of primary hyperparathyroidism: bone mineral density and fracture risk","volume":"16","author":"Lewiecki","year":"2013","journal-title":"J Clin Densitom"},{"issue":"2","key":"2024012714065944400_jbmr4677-bib-0065","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jocd.2018.06.005","article-title":"Usefulness of trabecular bone score (TBS) to identify Bone fragility in patients with primary hyperparathyroidism","volume":"22","author":"Munoz-Torres","year":"2019","journal-title":"J Clin Densitom"},{"issue":"5","key":"2024012714065944400_jbmr4677-bib-0066","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/jbmr.1841","article-title":"Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women","volume":"28","author":"Stein","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2024012714065944400_jbmr4677-bib-0067","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1210\/jc.2014-1415","article-title":"Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Silverberg","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2024012714065944400_jbmr4677-bib-0068","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1210\/jc.2011-0569","article-title":"Nephrolithiasis and renal calcifications in primary hyperparathyroidism","volume":"96","author":"Rejnmark","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024012714065944400_jbmr4677-bib-0069","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.urology.2014.01.016","article-title":"Determinants of urolithiasis before and after parathyroidectomy in patients with primary hyperparathyroidism","volume":"84","author":"Elkoushy","year":"2014","journal-title":"Urology"},{"issue":"9","key":"2024012714065944400_jbmr4677-bib-0070","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1210\/jc.2018-00923","article-title":"Predictors of renal function and calcifications in primary hyperparathyroidism: a nested case-control study","volume":"103","author":"Ejlsmark-Svensson","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024012714065944400_jbmr4677-bib-0071","doi-asserted-by":"crossref","first-page":"60","DOI":"10.11138\/ccmbm\/2017.14.1.060","article-title":"Molecular genetics in primary hyperparathyroidism: the role of genetic tests in differential diagnosis, disease prevention strategy, and therapeutic planning. A 2017 update","volume":"14","author":"Marini","year":"2017","journal-title":"Clin Cases Miner Bone Metab"},{"issue":"3","key":"2024012714065944400_jbmr4677-bib-0072","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1530\/EJE-14-0343","article-title":"Factors associated with vertebral fracture risk in patients with primary hyperparathyroidism","volume":"171","author":"Eller-Vainicher","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2024012714065944400_jbmr4677-bib-0073","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/eje.1.02286","article-title":"R990G polymorphism of the calcium-sensing receptor and renal calcium excretion in patients with primary hyperparathyroidism","volume":"155","author":"Corbetta","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2024012714065944400_jbmr4677-bib-0074","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s42255-020-0175-z","article-title":"PTH hypersecretion triggered by a GABAB1 and Ca(2+)-sensing receptor heterocomplex in hyperparathyroidism","volume":"2","author":"Chang","year":"2020","journal-title":"Nat Metab"},{"issue":"1","key":"2024012714065944400_jbmr4677-bib-0075","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1210\/jc.2006-0857","article-title":"Primary hyperparathyroidism and the presence of kidney stones are associated with different haplotypes of the calcium-sensing receptor","volume":"92","author":"Scillitani","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024012714065944400_jbmr4677-bib-0076","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13023-020-01380-1","article-title":"Bone tissue and mineral metabolism in hereditary endocrine tumors: clinical manifestations and genetic bases","volume":"15","author":"Maraghelli","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"2024012714065944400_jbmr4677-bib-0077","author":"NHS Hyperparathyroidism","year":"2020"},{"key":"2024012714065944400_jbmr4677-bib-0078","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1472-6890-8-12","article-title":"Derivation and internal validation of an equation for albumin-adjusted calcium","volume":"8","author":"James","year":"2008","journal-title":"BMC Clin Pathol"},{"key":"2024012714065944400_jbmr4677-bib-0079","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/cen.14326","article-title":"Reference interval for albumin-adjusted calcium based on a large UK population","volume":"94","author":"Schini","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2024012714065944400_jbmr4677-bib-0080","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/cen.14362","article-title":"Measuring serum calcium: total, albumin-adjusted or ionized?","volume":"95","author":"Minisola","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2024012714065944400_jbmr4677-bib-0081","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1515\/cclm-2019-0568","article-title":"Calcium state estimation by total calcium: the evidence to end the never-ending story","volume":"58","author":"Pekar","year":"2020","journal-title":"Clin Chem Lab Med"},{"issue":"5","key":"2024012714065944400_jbmr4677-bib-0082","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.amjsurg.2013.01.017","article-title":"Ionized vs serum calcium in the diagnosis and management of primary hyperparathyroidism: which is superior?","volume":"205","author":"Tee","year":"2013","journal-title":"Am J Surg"},{"issue":"8","key":"2024012714065944400_jbmr4677-bib-0083","doi-asserted-by":"crossref","first-page":"989","DOI":"10.4158\/EP171761.RA","article-title":"Biotin interference with routine clinical immunoassays: understand the causes and mitigate the risks","volume":"23","author":"Samarasinghe","year":"2017","journal-title":"Endocr Pract"},{"issue":"18","key":"2024012714065944400_jbmr4677-bib-0084","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1093\/hmg\/ddv226","article-title":"Adapter protein-2 sigma subunit mutations causing familial hypocalciuric hypercalaemia type 3 (FHH3) demonstrate genotype-phenotype correlations, codon bias and dominant-negative effects","volume":"24","author":"Hannan","year":"2015","journal-title":"Hum Mol Genet"},{"key":"2024012714065944400_jbmr4677-bib-0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4158\/EP-2018-0350","article-title":"Calcium creatinine clearance ratio is not helpful in differentiating primary hyperparathyroidism from familial hypercalcemic hypocalciuria: a study of 1000 pateients","volume":"24","author":"Moore","year":"2018","journal-title":"Endocr Pract"},{"key":"2024012714065944400_jbmr4677-bib-0086","first-page":"1017","volume-title":"Principles of Bone Biology","author":"Fuleihan","year":"2002"},{"issue":"1151","key":"2024012714065944400_jbmr4677-bib-0087","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/postgradmedj-2020-137718","article-title":"Urinary calcium indices in primary hyperparathyroidism (PHPT) and familial hypocalciuric hypercalcaemia (FHH): which test performs test?","volume":"97","author":"Arshad","year":"2021","journal-title":"Postgrad Med J"},{"issue":"9817","key":"2024012714065944400_jbmr4677-bib-0088","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(11)61516-X","article-title":"Lithium toxicity profile: a systematic review and meta-analysis","volume":"379","author":"McKnight","year":"2012","journal-title":"Lancet"},{"key":"2024012714065944400_jbmr4677-bib-0089","doi-asserted-by":"crossref","first-page":"6316","DOI":"10.1210\/jc.2005-0675","article-title":"Rare causes of hypercalcemia","volume":"90","author":"Jacobs","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2024012714065944400_jbmr4677-bib-0090","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1210\/clinem\/dgab504","article-title":"Rare causes of hypercalcemia: 2021 update","volume":"106","author":"Motlaghzadeh","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2024012714065944400_jbmr4677-bib-0091","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/jama.1934.02750160010003","article-title":"Hyperparathyroidism: a common and polymorphic condition as illustrated by seventeen proved cases from one clinic","volume":"102","author":"Albright","year":"1934","journal-title":"JAMA"},{"key":"2024012714065944400_jbmr4677-bib-0092","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.endonu.2013.04.014","article-title":"Spontaneous neck hematoma due to rupture of parathyroid adenoma: report of 3 cases and literature review","volume":"61","author":"Osorio","year":"2014","journal-title":"Endocrinol Nutr"},{"key":"2024012714065944400_jbmr4677-bib-0093","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2018.09.004","article-title":"Primary hyperparathyroidism","volume":"32","author":"Silva","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"4","key":"2024012714065944400_jbmr4677-bib-0094","doi-asserted-by":"crossref","first-page":"e1171","DOI":"10.1210\/clinem\/dgaa084","article-title":"Normocalcemic hyperparathyroidism: study of its prevalence and natural history","volume":"105","author":"Schini","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024012714065944400_jbmr4677-bib-0095","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4158\/EP15704.OR","article-title":"Primary hyperparathyroidism with a focus on management of the normocalcemic form: to treat or not to treat?","volume":"22","author":"\u0160iprov\u00e1","year":"2016","journal-title":"Endocr Pract"},{"issue":"1","key":"2024012714065944400_jbmr4677-bib-0096","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.amjsurg.2019.10.032","article-title":"Comparative prospective study on the presentation of normocalcemic primary hyperparathyroidism. Is it more aggressive than the hypercalcemic form?","volume":"19","author":"G\u00f3mez-Ram\u00edrez","year":"2020","journal-title":"Am J Surg"},{"issue":"4","key":"2024012714065944400_jbmr4677-bib-0097","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1177\/0194599818793879","article-title":"Surgical management of normocalcemic primary hyperparathyroidism and the impact of intraoperative parathyroid hormone testing on outcome","volume":"159","author":"Trinh","year":"2018","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"8","key":"2024012714065944400_jbmr4677-bib-0098","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1210\/jc.2013-1518","article-title":"Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism","volume":"98","author":"Koumakis","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2024012714065944400_jbmr4677-bib-0099","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1007\/s00198-014-2689-2","article-title":"Individual site-specific bone mineral density gain in normocalcemic primary hyperparathyroidism","volume":"25","author":"Koumakis","year":"2014","journal-title":"Osteoporos Int"},{"key":"2024012714065944400_jbmr4677-bib-0100","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/B978-0-12-397166-1.00031-X","volume-title":"The Parathyroids","author":"Peacock","year":"2015"},{"key":"2024012714065944400_jbmr4677-bib-0101","first-page":"349","article-title":"Changes in urinary risk profile after short-term low sodium and low calcium ciet in recurrent Swiss kidney stone formers","volume":"18","author":"Seeger","year":"2017","journal-title":"Nephrol Ther"},{"issue":"7","key":"2024012714065944400_jbmr4677-bib-0102","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1308\/rcsann.2017.0092","article-title":"Changes in bone turnover markers in primary hyperparathyroidism and response to surgery","volume":"99","author":"Rajeev","year":"2017","journal-title":"Ann R Coll Surg Engl"},{"issue":"9","key":"2024012714065944400_jbmr4677-bib-0103","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/jbmr.3177","article-title":"Effect of surgery versus observation: skeletal 5-year outcomes in a randomized trial of patients with primary HPT (the SIPH study)","volume":"32","author":"Lundstam","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2024012714065944400_jbmr4677-bib-0104","first-page":"640","article-title":"The usefulness of high pre-operative levels of serum type I collagen bone markers for the prediction of changes in bone mineral density after parathyroidectomy","volume":"35","author":"Alonso","year":"2012","journal-title":"J Endocrinol Invest"},{"key":"2024012714065944400_jbmr4677-bib-0105","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","article-title":"Primary hyperparathyroidism and the risk of fracture: a population based study","volume":"14","author":"Khosla","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2024012714065944400_jbmr4677-bib-0106","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1210\/jc.2008-2006","article-title":"Morphometic vertebral fractures in postmenopausal women with primary hyperparathyroidism","volume":"94","author":"Vignali","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2024012714065944400_jbmr4677-bib-0107","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2796.1993.tb01017.x","article-title":"The risk of hip fractures in patients with primary hyperparathyroidism: a population-based cohort study with a follow-up of 19\u2009years","volume":"234","author":"Larsson","year":"1993","journal-title":"J Intern Med"},{"issue":"6","key":"2024012714065944400_jbmr4677-bib-0108","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00198-021-05822-9","article-title":"Risk of fractures in primary hyperparathyroidism: a systematic review and meta-analysis","volume":"32","author":"Ejlsmark-Svensson","year":"2021","journal-title":"Osteoporos Int"},{"issue":"3","key":"2024012714065944400_jbmr4677-bib-0109","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1530\/eje.1.02225","article-title":"The risk of fractures in postmenopausal women with primary hyperparathyroidism","volume":"155","author":"De Geronimo","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2024012714065944400_jbmr4677-bib-0110","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/jbmr.3461","article-title":"Prevalence and risk of vertebral fractures in primary hyperparathyroidism: a nested case-control study","volume":"33","author":"Ejlsmark-Svensson","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"Suppl I","key":"2024012714065944400_jbmr4677-bib-0111","first-page":"59A","article-title":"Reversal of lumbar spine osteopenia after parathyroidectomy in primary hyperparathyroidism","volume":"10","author":"Silverberg","year":"1995","journal-title":"J Bone Miner Res"},{"issue":"9","key":"2024012714065944400_jbmr4677-bib-0112","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1210\/jc.2007-1215","article-title":"The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15\u2009years","volume":"93","author":"Rubin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2024012714065944400_jbmr4677-bib-0113","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11657-018-0510-0","article-title":"A brief history of FRAX","volume":"31","author":"Kanis","year":"2018","journal-title":"Arch Osteoporosis"},{"key":"2024012714065944400_jbmr4677-bib-0114","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/jbmr.98","article-title":"Effects of bone geometry, desntiy and microatchitecture in the distal radius but not the tibia in women with primary hyperparathyroidism: a case-control study using HR-pQCT","volume":"25","author":"Hansen","year":"2010","journal-title":"J Bone Miner Res"},{"key":"2024012714065944400_jbmr4677-bib-0115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00198-019-05186-1","article-title":"Impaired geometry, volumetric density, and microstructure of cortical and trabecular bone assessed by HR-pQCT in both sporadic and MEN-1 related primary hyperparathyroidism","volume":"31","author":"Wang","year":"2020","journal-title":"Osteoporosis Int"},{"issue":"1","key":"2024012714065944400_jbmr4677-bib-0116","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0889-8529(18)30337-2","article-title":"Bone disease in primary hyperparathyroidism","volume":"19","author":"Parisien","year":"1990","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"2024012714065944400_jbmr4677-bib-0117","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1210\/jc.2012-4255","article-title":"Trabecular bone score (TBS)--a novel method to evaluate bone microarchitectural texture in patients with primary hyperparathyroidism","volume":"98","author":"Silva","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024012714065944400_jbmr4677-bib-0118","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1530\/EJE-13-0305","article-title":"Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism","volume":"169","author":"Eller-Vainicher","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2024012714065944400_jbmr4677-bib-0119","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bone.2012.11.041","article-title":"\"Trabecular Bone Score\" (TBS): an indirect measure of bone micro-architecture in postmenopausal patients with primary hyperparathyroidism","volume":"53","author":"Romagnoli","year":"2013","journal-title":"Bone"},{"issue":"2","key":"2024012714065944400_jbmr4677-bib-0120","first-page":"208","article-title":"Trabecular bone score (TBS) has a poor discriminative power for vertebral fractures in 153 Romanian patients with primary hyperparathyroidism","volume":"14","author":"Grigorie","year":"2018","journal-title":"Acta Endocrinol"},{"issue":"3","key":"2024012714065944400_jbmr4677-bib-0121","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s12020-019-02099-1","article-title":"Risk factors for vertebral fracture in primary hyperparathyroidism","volume":"66","author":"Liu","year":"2019","journal-title":"Endocrine"},{"key":"2024012714065944400_jbmr4677-bib-0122","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1210\/jc.2015-2132","article-title":"Parathyroidectomy halts the deterioration of renal function in primary hyperparathyroidism","volume":"100","author":"Tassone","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024012714065944400_jbmr4677-bib-0123","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4103\/2230-8210.172285","article-title":"Surgery or no surgery: what works best for the kidneys in primary hyperparathyroidism? A study in a multi-ethnic Asian population","volume":"20","author":"Tay","year":"2016","journal-title":"Indian J Endocrinol Metab"},{"issue":"3","key":"2024012714065944400_jbmr4677-bib-0124","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/cen.14311","article-title":"A detailed appraisal of renal manifestations in primary hyperparathyroidism from registry: before and after curative parathyroidectomy","volume":"94","author":"Agrawal","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"2024012714065944400_jbmr4677-bib-0125","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1210\/jc.2006-0070","article-title":"A slight decrease in renal function further impairs bone mineral density in primary hyperparathyroidism","volume":"91","author":"Gianotti","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2024012714065944400_jbmr4677-bib-0126","article-title":"2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"KDIGO","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"2024012714065944400_jbmr4677-bib-0127","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00198-005-1903-7","article-title":"In elderly men and women treated for osteoporosis and low creatinine clearance of &lt;65 ml\/min is a risk factor for falls and fractures","volume":"16","author":"Dukas","year":"2005","journal-title":"Osteoporosis Int"},{"key":"2024012714065944400_jbmr4677-bib-0128","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/archinte.167.2.133","article-title":"Renal function and risk of hip and vertebral fractures in older women","volume":"167","author":"Ensrud","year":"2007","journal-title":"Arch Int Med"},{"key":"2024012714065944400_jbmr4677-bib-0129","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1681\/ASN.2006050546","article-title":"Association of kidney function with incident hip fracture in older adults","volume":"18","author":"Fried","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2024012714065944400_jbmr4677-bib-0130","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1681\/ASN.2005111194","article-title":"Relationship between moderate to severe kidney disease and hip fracture in the United States","volume":"17","author":"Nickolas","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"2024012714065944400_jbmr4677-bib-0131","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/bju.15250","article-title":"Utility of blood tests in screening for metabolic disorders in kidney stone disease","volume":"127","author":"Eyre","year":"2021","journal-title":"BJU Int"},{"key":"2024012714065944400_jbmr4677-bib-0132","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0140-6736(06)68071-9","article-title":"Kidney stones: pathophysiology and medical management","volume":"367","author":"Moe","year":"2006","journal-title":"Lancet"},{"issue":"8","key":"2024012714065944400_jbmr4677-bib-0133","doi-asserted-by":"crossref","first-page":"e2789","DOI":"10.1210\/clinem\/dgaa233","article-title":"Hypomagnesuria is associated with nephrolithiasis in patients with asymptomatic primary hyperparathyroidism","volume":"105","author":"Saponaro","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024012714065944400_jbmr4677-bib-0134","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00240-007-0096-2","article-title":"Biochemical characterization of primary hyperparathyroidism with and without kidney stones","volume":"35","author":"Odvina","year":"2007","journal-title":"Urol Res"},{"issue":"2","key":"2024012714065944400_jbmr4677-bib-0135","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4158\/EP161476.OR","article-title":"Nephrolithiasis in primary hyperparathyroidism: a comparison between silent and symptomatic patients","volume":"23","author":"Castellano","year":"2017","journal-title":"Endocr Pract"},{"key":"2024012714065944400_jbmr4677-bib-0136","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/07435800.2018.1431275","article-title":"Occult urolithiasis in asymptomatic primary hyperparathyroidism","volume":"43","author":"Tay","year":"2018","journal-title":"Endocr Res"},{"key":"2024012714065944400_jbmr4677-bib-0137","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s40618-019-01162-y","article-title":"Hypercalciuria: its value as a predictive risk factor for nephrolithiasis in asymptomatic primary hyperparathyroidism","volume":"43","author":"Saponaro","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"2024012714065944400_jbmr4677-bib-0138","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/sj.ki.5002708","article-title":"24-h uric acid excretion and the risk of kidney stones","volume":"73","author":"Curhan","year":"2008","journal-title":"Kidney Int"},{"issue":"11","key":"2024012714065944400_jbmr4677-bib-0139","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4158\/EP14074.OR","article-title":"Silent renal stones in primary hyperparathyroidism: prevalence and clinical features","volume":"20","author":"Cassibba","year":"2014","journal-title":"Endocr Pract"},{"key":"2024012714065944400_jbmr4677-bib-0140","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4103\/0022-3859.81859","article-title":"Salutary effect of parathyroidectomy on neuropsychiatric symptoms in patients with primary hyperparathyroidism: evaluation using PAS and SF-36v2 scoring systems","volume":"57","author":"Ramakant","year":"2011","journal-title":"J Postgrad Med"},{"issue":"6","key":"2024012714065944400_jbmr4677-bib-0141","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.surg.2009.09.034","article-title":"Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with \u201casymptomatic\u201d primary hyperparathyroidism","volume":"146","author":"Perrier","year":"2009","journal-title":"Surgery"},{"issue":"7","key":"2024012714065944400_jbmr4677-bib-0142","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1176\/appi.ajp.2017.16111226","article-title":"Psychiatric complications of primary hyperparathyroidism and mild hypercalcemia","volume":"174","author":"Parks","year":"2017","journal-title":"Am J Psychiatry"},{"issue":"1","key":"2024012714065944400_jbmr4677-bib-0143","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.surg.2020.06.006","article-title":"Neuropsychologic changes in primary hyperparathyroidism after parathyroidectomy from a dual-institution prospective study","volume":"169","author":"Liu","year":"2021","journal-title":"Surgery"},{"issue":"10","key":"2024012714065944400_jbmr4677-bib-0144","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg"},{"key":"2024012714065944400_jbmr4677-bib-0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.4199","article-title":"Effects of parathyroidectomy on quality of life: 10\u2009years of data from a prospective randomized controlled trial on primary hyperparathyroidism (the SIPH-study)","volume":"36","author":"Pretorius","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2024012714065944400_jbmr4677-bib-0146","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5005\/jp-journals-10002-1209","article-title":"Assessment of cardiovascular system abnormalities in patients with advanced primary hyperparathyroidism by detailed echocardiographic analysis: a prospective study","volume":"9","author":"Mishra","year":"2017","journal-title":"World J Endocr Surg"},{"issue":"5","key":"2024012714065944400_jbmr4677-bib-0147","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1530\/EJE-09-1067","article-title":"Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism","volume":"162","author":"Tordjman","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"2024012714065944400_jbmr4677-bib-0148","doi-asserted-by":"crossref","first-page":"408295","DOI":"10.1155\/2012\/408295","article-title":"Arterial hypertension, metabolic syndrome and subclinical cardiovascular organ damage in patients with asymptomatic primary hyperparathyroidism before and after parathyroidectomy: preliminary results","volume":"2012","author":"Luigi","year":"2012","journal-title":"Int J Endocrinol"},{"key":"2024012714065944400_jbmr4677-bib-0149","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1530\/EC-18-0259","article-title":"The effect of surgery on fat mass, lipid and glucose metabolism in mild primary hyperparathyroidism","volume":"7","author":"Godang","year":"2018","journal-title":"Endocr Connect"},{"issue":"1","key":"2024012714065944400_jbmr4677-bib-0150","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12872-019-1093-4","article-title":"Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism","volume":"19","author":"Beysel","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"2024012714065944400_jbmr4677-bib-0151","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2265.2010.03909.x","article-title":"Effect of surgery on cardiac structure and function in mild primary hyperparathyroidism","volume":"74","author":"Persson","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"2024012714065944400_jbmr4677-bib-0152","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1210\/jc.2004-0028","article-title":"Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism","volume":"89","author":"Rao","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2024012714065944400_jbmr4677-bib-0153","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1210\/jc.2007-0219","article-title":"Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective randomized clinical trial","volume":"92","author":"Ambrogini","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2024012714065944400_jbmr4677-bib-0154","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/bjs.7044","article-title":"Effect of parathyroidectomy for primary hyperparathyroidism on bone mineral density in postmenopausal women","volume":"97","author":"Sitges-Serra","year":"2010","journal-title":"Br J Surg"},{"issue":"6","key":"2024012714065944400_jbmr4677-bib-0155","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1067\/msy.2002.128692","article-title":"Cardiac dysfunction in mild primary hyperparathyroidism assessed by radionuclide angiography and echocardiography before and after parathyroidectomy","volume":"132","author":"Almqvist","year":"2002","journal-title":"Surgery"},{"issue":"6","key":"2024012714065944400_jbmr4677-bib-0156","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.surg.2004.06.059","article-title":"Early parathyroidectomy increases bone mineral density in patients with mild primary hyperparathyroidism: a prospective and randomized study","volume":"136","author":"Almqvist","year":"2004","journal-title":"Surgery"},{"issue":"8","key":"2024012714065944400_jbmr4677-bib-0157","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1210\/jc.2018-02456","article-title":"Effect of parathyroidectomy on cardiovascular risk factors in primary hyperparathyroidism: a randomized clinical trial","volume":"104","author":"Ejlsmark-Svensson","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2024012714065944400_jbmr4677-bib-0158","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/SLA.0b013e3181d76bb3","article-title":"Parathyroidectomy improves functional capacity in \"asymptomatic\" older patients with primary hyperparathyroidism: a randomized control trial","volume":"251","author":"Morris","year":"2010","journal-title":"Ann Surg"},{"issue":"4","key":"2024012714065944400_jbmr4677-bib-0159","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1210\/jc.2014-3441","article-title":"Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild primary hyperparathyroidism","volume":"100","author":"Lundstam","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2024012714065944400_jbmr4677-bib-0160","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00268-007-9068-5","article-title":"1112 Consecutive bilateral neck explorations for primary hyperparathyroidism","volume":"31","author":"Allendorf","year":"2007","journal-title":"World J Surg"},{"key":"2024012714065944400_jbmr4677-bib-0161","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/SLA.0b013e318208fed9","article-title":"The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism","volume":"253","author":"Udelsman","year":"2011","journal-title":"Ann Surg"},{"key":"2024012714065944400_jbmr4677-bib-0162","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1210\/jcem.83.8.5006","article-title":"Thresholds for surgery and surgical outcomes for patients with primary hyperparathyroidism: a national survey of endocrine surgeons","volume":"83","author":"Sosa","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024012714065944400_jbmr4677-bib-0163","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/1754-9485.12728","article-title":"Better performance of four-dimension computed tomography as a localization procedure in normocalcemic primary hyperparathyroidism","volume":"62","author":"Cunha-Bezerra","year":"2018","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"1","key":"2024012714065944400_jbmr4677-bib-0164","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.surg.2019.06.043","article-title":"Normocalcemic hyperparathyroidism: a collaborative endocrine surgery quality improvement program analysis","volume":"167","author":"Pandian","year":"2020","journal-title":"Surgery"},{"key":"2024012714065944400_jbmr4677-bib-0165","doi-asserted-by":"crossref","first-page":"2150159","DOI":"10.1155\/2019\/2150159","article-title":"Do symptoms and serum calcium levels affect the results of surgical treatment of primary hyperparathyroidism?","volume":"2019","author":"Yu","year":"2019","journal-title":"Biomed Res Int"},{"issue":"10","key":"2024012714065944400_jbmr4677-bib-0166","first-page":"CD019787","article-title":"Minimally invasive parathyroidectomy guided by intraoperative parathyroid hormone monitoring (IOPTH) and preoperative imaging versus bilateral neck exploration for primary hyperparathyroidism in adults","volume":"10","author":"Almadieh","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2024012714065944400_jbmr4677-bib-0167","first-page":"171","article-title":"Postsurgical hypoparathyroidism: a systematic review","volume":"30","author":"Karava","year":"2016","journal-title":"In Vivo"},{"key":"2024012714065944400_jbmr4677-bib-0168","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1210\/clinem\/dgaa113","article-title":"Hypoparathyroidism","volume":"105","author":"Bilezikian","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2024012714065944400_jbmr4677-bib-0169","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1007\/s00268-018-4629-3","article-title":"Patient frailty should be used to individualize treatment decision in primary hyperparathyroidism","volume":"42","author":"Seib","year":"2018","journal-title":"World J Surg"},{"issue":"1","key":"2024012714065944400_jbmr4677-bib-0170","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00423-012-1026-5","article-title":"BMD improvements after operation for primary hyperparathyroidism","volume":"398","author":"Rolighed","year":"2013","journal-title":"Langenbecks Arch Surg"},{"issue":"2","key":"2024012714065944400_jbmr4677-bib-0171","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1245\/s10434-018-6998-0","article-title":"Biochemical and skeletal outcomes of parathyroidectomy for Normocalcemic (incipient) primary hyperparathyroidism","volume":"26","author":"Sho","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2024012714065944400_jbmr4677-bib-0172","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.surg.2018.04.065","article-title":"Bone mineral density changes after parathyroidectomy are dependent on biochemical profile","volume":"165","author":"Lee","year":"2019","journal-title":"Surgery"},{"issue":"7368","key":"2024012714065944400_jbmr4677-bib-0173","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/bmj.325.7368.807","article-title":"Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study","volume":"325","author":"Mollerup","year":"2002","journal-title":"Br Med J"},{"issue":"4","key":"2024012714065944400_jbmr4677-bib-0174","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jocd.2019.07.001","article-title":"Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA cross-calibration and least significant change, spinal cord injury, periprosthetic and orthopedic bone health, transgender medicine, and pediatrics","volume":"22","author":"Shuhart","year":"2019","journal-title":"J Clin Densitom"},{"key":"2024012714065944400_jbmr4677-bib-0175","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S2213-8587(20)30159-5","article-title":"Treatment-related changes in bone mineral density as a surrogate biomarker for fracture risk reduction: meta-regression analyses of individual patient data from multiple randomised controlled trials","volume":"8","author":"Black","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2024012714065944400_jbmr4677-bib-0176","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1210\/jc.2014-1417","article-title":"Medical management of primary hyperparathyroidism: proceedings of the Fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism","volume":"99","author":"Marcocci","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2024012714065944400_jbmr4677-bib-0177","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/jc.2010-2704","article-title":"The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know","volume":"96","author":"Ross","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2024012714065944400_jbmr4677-bib-0178","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/cen.12398","article-title":"Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: a meta-analysis and review of literature","volume":"80","author":"Shah","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024012714065944400_jbmr4677-bib-0179","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jbmr.328","article-title":"Why the IOM recommendations for vitamin D are deficient","volume":"26","author":"Heaney","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2024012714065944400_jbmr4677-bib-0180","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4158\/EP10202.OR","article-title":"Vitamin D status and its relationship with bone mineral density and parathryoid hormone in Southeast Asian adults with low bone density","volume":"17","author":"Chandran","year":"2011","journal-title":"Endocr Pract"},{"key":"2024012714065944400_jbmr4677-bib-0181","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1210\/jc.2015-2022","article-title":"Vitamin D in primary hyperparathyroidism: effects on clinical, biochemical, and densitometric presentation","volume":"100","author":"Walker","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2024012714065944400_jbmr4677-bib-0182","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1210\/jc.2013-3978","article-title":"Vitamin D treatment in primary hyperparathyroidism: a randomized placbo-controlled trial","volume":"99","author":"Rolighed","year":"2014","journal-title":"J Clin Endocinol Metab"},{"key":"2024012714065944400_jbmr4677-bib-0183","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1530\/EJE-14-0940","article-title":"No beneficial effect of vitamin D supplementation on muscle function or quality of life inn primary hyperparathyroidism: results from a randomized controlled trial","volume":"172","author":"Rolighed","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"2024012714065944400_jbmr4677-bib-0184","first-page":"250","article-title":"Treatment with active vitamin D (alphacalcidol) in patients with mild primary hyperparathyroidism","volume":"120","author":"Lind","year":"1989","journal-title":"Acta Endocrinol"},{"issue":"8","key":"2024012714065944400_jbmr4677-bib-0185","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s40618-020-01473-5","article-title":"Safety and efficacy of common vitamin D supplementaiton in primary hyperparathyroidism and coexistent vitamin D deficiency and insufficiency: a systematic review and meta-analysis","volume":"44","author":"Song","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"2024012714065944400_jbmr4677-bib-0186","doi-asserted-by":"crossref","first-page":"221","DOI":"10.23736\/S0391-1977.17.02584-6","article-title":"Effect of vitamin D replacement in primary hyperparathyroidism with concurrent vitamin D deficiency: a systematic review and meta-analysis","volume":"44","author":"Loh","year":"2019","journal-title":"Minerva Endocrinol"},{"key":"2024012714065944400_jbmr4677-bib-0187","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12020-016-1169-1","article-title":"Vitamin D and primary hyperparathyroidism: more insights into a complex relationship","volume":"55","author":"Walker","year":"2017","journal-title":"Endocrine"},{"key":"2024012714065944400_jbmr4677-bib-0188","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7326\/M15-1232","article-title":"The relationship of parathyroidectomy and bisphosphonates with fracture risk in primary hyperparathyroidism: an observational study","volume":"164","author":"Yeh","year":"2016","journal-title":"Ann Intern Med"},{"key":"2024012714065944400_jbmr4677-bib-0189","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.surg.2019.04.059","article-title":"Skeletal effects of combined medical and surgical management of primary hyperparathyroidism","volume":"167","author":"Orr","year":"2020","journal-title":"Surgery"},{"key":"2024012714065944400_jbmr4677-bib-0190","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1210\/jc.2003-030908","article-title":"Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial","volume":"89","author":"Khan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2024012714065944400_jbmr4677-bib-0191","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4158\/EP08178.ORR","article-title":"Alendronate therapy in men with primary hyperparathyroidism","volume":"15","author":"Khan","year":"2009","journal-title":"Endocr Pract"},{"key":"2024012714065944400_jbmr4677-bib-0192","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00774-013-0473-6","article-title":"Effect of parathyroidectomy versus risedronate on volumetric bone mineral density and bone geometry at the tibia in postmenopausal women with primary hyperparathyroidism","volume":"32","author":"Tournis","year":"2014","journal-title":"J Bone Miner Metab"},{"key":"2024012714065944400_jbmr4677-bib-0193","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/jc.2002-020890","article-title":"Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism","volume":"88","author":"Chow","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2024012714065944400_jbmr4677-bib-0194","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1359\/jbmr.2001.16.1.113","article-title":"Effects of oral alendronate in 20 elderly patients with osteoporosis and mild primary hyperparathyroidism","volume":"16","author":"Rossini","year":"2001","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2024012714065944400_jbmr4677-bib-0195","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00198-014-3000-2","article-title":"Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism","volume":"26","author":"Cesareo","year":"2015","journal-title":"Osteoporos Int"},{"key":"2024012714065944400_jbmr4677-bib-0196","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1001\/archinte.160.14.2161","article-title":"Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism four-year follow-up and comparison with healthy postmenopausal women","volume":"160","author":"Orr-Walker","year":"2000","journal-title":"Arch Intern Med"},{"key":"2024012714065944400_jbmr4677-bib-0197","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7326\/0003-4819-125-5-199609010-00002","article-title":"Effect of hormone replacement therapy on bone mineral dentiy in postmenopsausal women with mild primary hyperparathyroidism: a randomized controlled trial","volume":"125","author":"Grey","year":"1996","journal-title":"Ann Intern Med"},{"key":"2024012714065944400_jbmr4677-bib-0198","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jc.2002-020667","article-title":"Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism","volume":"88","author":"Rubin","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2024012714065944400_jbmr4677-bib-0199","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s12020-020-02401-6","article-title":"Effects of denosumab as compared with parathyroidectomy regarding calcium, renal, and bone involvement in osteoporotic patients with primary hyperparathyroidism","volume":"69","author":"Miyaoka","year":"2020","journal-title":"Endocrine"},{"key":"2024012714065944400_jbmr4677-bib-0200","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/jgs.15250","article-title":"Protective effect of denosumab on bone in older women with primary hyperparathyroidism","volume":"66","author":"Eller-Vainicher","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"2024012714065944400_jbmr4677-bib-0201","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1210\/jc.2009-1472","article-title":"Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study","volume":"94","author":"Peacock","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2024012714065944400_jbmr4677-bib-0202","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1530\/EJE-14-0877","article-title":"Cinacalcet normalizes serum calcium in a double-blind randomized placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgery","volume":"172","author":"Khan","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"2024012714065944400_jbmr4677-bib-0203","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s11154-021-09694-6","article-title":"The efficacy and safety of cinacalcet in primary hyperparathyroidism: a systematic review and meta-analysis of randomized controlled trials and cohort studies","volume":"23","author":"Chandran","year":"2022","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"2024012714065944400_jbmr4677-bib-0204","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4081\/aiua.2015.1.66","article-title":"Use of cinacalcet in nephrolithiasis associated with normocalcemic or hypercalcemic primary hyperparathyroidism: results of a prospective randomized pilot study","volume":"87","author":"Brardi","year":"2015","journal-title":"Arch Ital Urol Androl"},{"key":"2024012714065944400_jbmr4677-bib-0205","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S2213-8587(20)30063-2","article-title":"Denosumab and cinacalcet for primary hyperparathyroidism (DENOCINA): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"8","author":"Leere","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"2024012714065944400_jbmr4677-bib-0206","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1210\/jc.2015-1110","article-title":"Pregnancy outcomes in women with primary hyperparathyroidism","volume":"100","author":"Hirsch","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024012714065944400_jbmr4677-bib-0207","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-13-0966","article-title":"Pregnancy outcomes in women with primary hyperparathyroidism","volume":"171","author":"Abood","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2024012714065944400_jbmr4677-bib-0208","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00404-014-3526-8","article-title":"Primary hyperparathyroidism during pregnancy","volume":"291","author":"Dochez","year":"2015","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"2024012714065944400_jbmr4677-bib-0209","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1365-2265.2008.03495.x","article-title":"Hyperparathyroidism during pregnancy and the effect of rising calcium on pregnancy loss: a call for earlier intervention","volume":"71","author":"Norman","year":"2009","journal-title":"Clin Endocrinol"},{"issue":"3","key":"2024012714065944400_jbmr4677-bib-0210","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ecl.2019.05.007","article-title":"Calcium metabolic disorders in pregnancy: primary hyperparathyroidism, pregnancy-induced osteoporosis, and vitamin D deficiency in pregnancy","volume":"48","author":"Leere","year":"2019","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2024012714065944400_jbmr4677-bib-0211","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S1526-9523(03)00148-X","article-title":"Wilkins drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk, 6th edition","volume":"48","author":"Hoover","year":"2003","journal-title":"J Midwifery Womens Health"},{"issue":"92","key":"2024012714065944400_jbmr4677-bib-0212","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/(SICI)1096-9926(199908)60:2<68::AID-TERA10>3.0.CO;2-H","article-title":"Transplacental effects of bishosphonates on fetal skeletal ossification and minerlization in rats","volume":"60","author":"Patlas","year":"1999","journal-title":"Teratology"},{"key":"2024012714065944400_jbmr4677-bib-0213","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bone.2014.04.002","article-title":"Infant cynomolgus monkeys exposed to denosumab in utero exhibit an osteoclast-poor osteopetrotic-like skeletal phenotype at birth and in the early postnatal period","volume":"64","author":"Boyce","year":"2014","journal-title":"Bone"},{"key":"2024012714065944400_jbmr4677-bib-0214","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13256-016-1093-2","article-title":"Primary hyperparathyroidism in pregnancy treated with cinacalcet: a case report and review of the literature","volume":"10","author":"Vera","year":"2016","journal-title":"J Med Case Rep"},{"key":"2024012714065944400_jbmr4677-bib-0215","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1308\/rcsann.2017.0014","article-title":"Evaluation of the radiation dose exposure and associated cancer risks in patients having preoperative parathyorid localization","volume":"99","author":"Moosvi","year":"2017","journal-title":"Ann R Coll Surg Engl"},{"key":"2024012714065944400_jbmr4677-bib-0216","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1097\/AOG.0000000000001316","article-title":"Committee on Obstetric Practice Committee Opinion No. 656: Guidelines for diagnostic imaging during pregnancy and lactation","volume":"127","author":"American College of Obstetricians and Gynecologists' Committee on Obstetric Practice","year":"2016","journal-title":"Obstet Gynecol"},{"key":"2024012714065944400_jbmr4677-bib-0217","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1148\/radiology.218.3.r01fe38783","article-title":"Comparison between MR imaging and99mTc MIBI scintigraphy in the evaluation of recurrent or persistent hyperparathyroidism","volume":"218","author":"Gotway","year":"2001","journal-title":"Radiology"},{"key":"2024012714065944400_jbmr4677-bib-0218","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.3390\/jcm10132956","article-title":"Primary hyperparathyroidism in pregnancy: literature review of the diagnosis and management","volume":"10","author":"Ali","year":"2021","journal-title":"J Clin Med"},{"key":"2024012714065944400_jbmr4677-bib-0219","first-page":"23","article-title":"Symptomatic hypocalcemia and hypoparathyroidism in two infants of mothers with hyperparathyroidism and familial benign hypercalcemia","volume":"15","author":"Thomas","year":"1995","journal-title":"J Perinatol"},{"issue":"5","key":"2024012714065944400_jbmr4677-bib-0220","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/jc.2006-1836","article-title":"Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial","volume":"92","author":"Bollerslev","year":"2007","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbmr.4677","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jbmr.4677","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/37\/11\/2293\/55456029\/jbmr4677.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/37\/11\/2293\/55456029\/jbmr4677.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T10:45:55Z","timestamp":1710326755000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/37\/11\/2293-2314\/7512381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":220,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,8,19]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.4677","relation":{"has-review":[{"id-type":"doi","id":"10.1002\/JBMR.4677\/v1\/review3","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4677\/v3\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4677\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4677\/v2\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4677\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4677\/v3\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4677\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4677\/v2\/review3","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4677\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4677\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4677\/v2\/response1","asserted-by":"object"}]},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12,1]]},"published":{"date-parts":[[2020,12,1]]},"assertion":[{"value":"2022-02-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}